$0.40
+0.05 (+13.15%)
Open$0.37
Previous Close$0.35
Day High$0.40
Day Low$0.36
52W High$22.17
52W Low$9.45
Volume—
Avg Volume109.4K
Market Cap148.67M
P/E Ratio20.92
EPS$0.81
SectorBiotechnology
Analyst Ratings
Buy
11 analysts
Price Target
+4,972.5% upside
Current
$0.40
$0.40
Target
$20.29
$20.29
$11.90
$20.29 avg
$29.33
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 23.05M | 23.70M | 20.49M |
| Net Income | -3,594,155 | -3,056,252 | -2,992,966 |
| Profit Margin | -15.6% | -12.9% | -14.6% |
| EBITDA | -5,194,179 | -4,785,189 | -3,856,552 |
| Free Cash Flow | -2,246,925 | -2,136,953 | -2,270,748 |
| Rev Growth | +13.8% | +16.7% | +8.2% |
| Debt/Equity | 0.77 | 0.64 | 0.68 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |